1. Assessment of extracellular field potential and Ca2 + transient signals for early QT/pro-arrhythmia detection using human induced pluripotent stem cell-derived cardiomyocytes;Abi-Gerges;Journal of Pharmacological and Toxicological Methods,2017
2. A new paradigm for drug-induced torsadogenic risk assessment using human iPS cell-derived cardiomyocytes;Ando;Journal of Pharmacological and Toxicological Methods,2017
3. 1ICH S7B: The nonclinical evaluation of the potential for delayed ventricular repolarization. CQT interval prolongation by Human Pharmaceuticals;Anon,2005
4. ICH E14: The clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs;Anon,2005
5. Improvement of acquisition and analysis methods in multi-electrode array experiments with iPS cell-derived cardiomyocytes;Asakura;Journal of Pharmacological and Toxicological Methods,2015